These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A, Yoshimura N. Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649 [Abstract] [Full Text] [Related]
5. Use of fluorescein and indocyanine green angiography in polypoidal choroidal vasculopathy patients following photodynamic therapy. Windisch R, Windisch BK, Cruess AF. Can J Ophthalmol; 2008 Dec; 43(6):678-82. PubMed ID: 19020634 [Abstract] [Full Text] [Related]
6. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Cho M, Barbazetto IA, Freund KB. Am J Ophthalmol; 2009 Jul; 148(1):70-8.e1. PubMed ID: 19403115 [Abstract] [Full Text] [Related]
8. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H. Retina; 2009 Oct; 29(7):960-5. PubMed ID: 19491727 [Abstract] [Full Text] [Related]
9. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Verteporfin In Photodynamic Therapy Study Group. Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929 [Abstract] [Full Text] [Related]
14. Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Nomura Y, Ueta T, Iriyama A, Inoue Y, Obata R, Tamaki Y, Yamaguchi T, Yanagi Y. Ophthalmology; 2011 May; 118(5):853-9. PubMed ID: 21095010 [Abstract] [Full Text] [Related]
15. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy. Yamashita A, Shiraga F, Shiragami C, Ono A, Tenkumo K. Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180 [Abstract] [Full Text] [Related]
16. Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration. Obata R, Yanagi Y, Kami J, Takahashi H, Inoue Y, Tamaki Y. Jpn J Ophthalmol; 2006 Mar; 50(4):354-360. PubMed ID: 16897221 [Abstract] [Full Text] [Related]
17. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N. Invest Ophthalmol Vis Sci; 2012 Jun 14; 53(7):3663-72. PubMed ID: 22570352 [Abstract] [Full Text] [Related]